首页> 外文期刊>Pathology International >Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.
【24h】

Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.

机译:乳腺核心针穿刺活检中“非典型导管增生”的临床病理学意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Atypical ductal proliferation or ADP has been used in histopathological diagnosis of core needle biopsy (CNB) but its details have not been well studied. Therefore, we examined the clinicopathological characteristics of the initial CNB cases diagnosed as 'ADP ' who subsequently turned out to be malignant, and compared the findings to those that did not. Among 101 cases initially diagnosed as ADP in CNB, the second biopsy revealed no carcinoma (38), ductal carcinoma in situ (DCIS) (45) and invasive carcinoma (18). Significant differences were detected between those which turned out to be carcinoma and those that did not, in the status of myoepithelial cells identified by p63 immunohistochemistry (P = 0.026) and ultrasound (US) categories (P < 0.001). We further compared the histopathological characteristics of those initially diagnosed as ADP and subsequently as DCIS or invasive ductal carcinoma (IDC) with those initially diagnosed as such. DCIS or IDC cases initially diagnosed as ADP had significantly lower Ki67 labeling index (P < 0.01, P < 0.01) and histological grade using Van nuys prognostic index (P < 0.01) or Nottingham histological grades (P < 0.01) respectively than those initially as DCIS or IDC. An assessment of myoepithelial components with US findings might contribute to determine the subsequent clinical algorithm of the patients diagnosed as ADP at initial CNB.
机译:非典型导管增生或ADP已用于核心穿刺活检(CNB)的组织病理学诊断,但其细节尚未得到很好的研究。因此,我们检查了最初被诊断为“ ADP”并随后被证实为恶性的CNB病例的临床病理特征,并将发现的结果与未发现的结果进行了比较。在最初被CNB诊断为ADP的101例患者中,第二次活检未发现癌(38),原位导管癌(DCIS)(45)和浸润性癌(18)。在通过p63免疫组织化学(P = 0.026)和超声(US)类别(P <0.001)鉴定的肌上皮细胞状态中,发现是癌的和没有癌的有显着差异。我们进一步比较了最初被诊断为ADP,随后被诊断为DCIS或浸润性导管癌(IDC)的组织病理学特征与最初被诊断为ADP的组织病理学特征。最初诊断为ADP的DCIS或IDC病例使用Van nuys预后指数(P <0.01)或诺丁汉组织学等级(P <0.01)分别显着降低Ki67标记指数(P <0.01,P <0.01)和组织学等级。 DCIS或IDC。评估具有US表现的肌上皮成分可能有助于确定最初的CNB时被诊断为ADP的患者的后续临床算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号